抑郁诊断后疾病聚类及其遗传决定因素:基于新型三维疾病网络的分析
研究开发三维疾病网络方法,在瑞典54,284例中年抑郁患者与496,005名匹配对照中识别抑郁后疾病聚类,并在英国生物银行验证。瑞典队列发现9个可靠聚类共85种疾病,其中6个聚类30种疾病在英国队列验证成功;PRS分析显示抑郁遗传易感性与后续疾病聚类易感性呈剂量反应关系,GWAS在4个聚类中识别8个全基因组显著位点。
要点
- 抑郁后存在6个可重复验证的疾病聚类,涉及中枢神经、呼吸、心血管代谢、胃肠、肌肉骨骼和精神障碍。
- 抑郁多基因风险评分与后续疾病聚类易感性呈剂量反应关系。
- GWAS在4个疾病聚类中识别出8个全基因组显著位点,提示共享和聚类特异性遗传基础。
核心结论
- 抑郁诊断后存在六个稳健疾病聚类,每个聚类具有共享和聚类特异性遗传基础。
研究设计与样本
- 研究基于瑞典国家登记匹配队列,纳入54,284例中年抑郁患者和496,005名年龄性别匹配未暴露个体,并在英国生物银行队列验证。
- 遗传分析使用英国生物银行10,754例抑郁患者的遗传数据,包括多基因风险评分(PRS)和全基因组关联研究(GWAS)。
- 研究开发三维网络方法,结合正则化偏相关,从非时间维度(x轴和y轴)和时间维度(z轴)识别并可视化疾病聚类。
主要发现
- 瑞典队列分析识别出9个可靠疾病聚类,由85种与抑郁相关的组成疾病构成。
- 其中6个聚类共30种疾病在英国生物银行队列成功验证,分别以中枢神经系统疾病、呼吸系统疾病、心血管和代谢疾病、胃肠道疾病、肌肉骨骼疾病和精神障碍为特征。
- PRS分析显示抑郁遗传易感性与后续疾病聚类易感性之间存在剂量反应关系。
- GWAS在四个疾病聚类中识别出八个全基因组显著位点。
临床怎么用
- 对抑郁患者进行后续疾病风险分层时,可关注中枢神经、呼吸、心血管代谢、胃肠、肌肉骨骼和精神障碍等聚类。
- 遗传易感性与后续疾病聚类易感性呈剂量反应关系,提示遗传信息可能用于风险预测研究。
局限性
- 研究结论需进一步研究基于遗传的风险预测和 therapeutic 干预开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depression is strongly associated with a range of subsequent diseases. To elucidate key mechanistic pathways for targeted interventions, this study aimed to determine the main disease networks associated with depression as well as their underlying genetic determinants. We developed a novel three-dimensional network approach which refines disease association verification by incorporating regularized partial correlations, and facilitates robust identification and visualization of disease clusters (i.e., groups of depression-associated diseases with high within-group connectivity) through both non-temporal (illustrating by x-axis and y-axis) and temporal (by z-axis) dimensions. We applied this approach to a matched cohort of 54,284 middle aged patients diagnosed with depression and their 496,005 age- and sex-matched unexposed individuals from the Swedish national registers and validated our findings in a cohort from the UK Biobank. Additionally, we conducted genetic analyses, including polygenic risk score (PRS) and genome-wide association studies (GWAS), using genetic data from 10,754 depression patients in the UK Biobank. Our analysis of the Swedish cohort identified nine reliable disease clusters consisting of 85 component diseases associated with depression, of which six clusters with 30 diseases were successfully validated using the UK Biobank cohort. These were clusters characterized by central nervous system (CNS) diseases, respiratory system diseases, cardiovascular and metabolic diseases, gastrointestinal diseases, musculoskeletal diseases, and mental disorders. PRS analysis revealed a dose-response relationship between genetic liability to depression and the susceptibility for subsequent disease clusters, while GWAS identified eight genome-wide significant loci in four of the clusters. Overall, our novel three-dimensional disease network approach identified six robust disease clusters after depression across two large cohorts, each with shared and cluster-specific genetic underpinnings. These findings warrant further research on genetic-based risk prediction and the development of therapeutic interventions aimed at health improvement for patients with depression.
引用
- Hou C, Liu H, Zeng Y, et al. Disease clusters and their genetic determinants following a diagnosis of depression: analyses based on a novel three-dimensional disease network approach. Mol Psychiatry. 2025. PMID: 40681841. doi:10.1038/s41380-025-03120-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。